Navigation Links
Nurses Launch National 'CheneyCare' Campaign
Date:1/4/2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...srupt normal development, mouse study finds , ... few glasses of wine over a short period in early ...chers from the Medical College of Georgia. , T...affects one in 1,000 babies, include facial malfor...ye openings, and a short nose. Researchers are inv...
(Date:8/29/2008)...-FirstCall/ -- Landauer, Inc. (NYSE:,LDR) announce...ular,quarterly cash dividend of $0.50 per share fo...will be paid on October 3, 2008, to shareholders o... Landauer is the leading provider of analytical se... radiation exposure. For more than 50 years,the C...
(Date:8/29/2008)...Telemedicine Encounter Management Systems (TEMS) t... possible solution to national health care problem...WEB) August 29, 2008 -- If there has been any one ...Democratic National Convention it has been the par...lth care issues., , ,Our Democratic leadership rec...
(Date:8/28/2008)...ia led to daytime tiredness, symptoms of depressio... -- Older adults who live with and provide direct ...ve significantly worse sleep than other older adul... 31 caregivers and 102 noncaregivers, ages 60 to 8...t than non-caregivers and took about 10 minutes lo...
Breaking Medicine News(10 mins):Health News:Alcohol in Early Pregnancy May Prompt Fetal Cell Death 2Health News:AMD Global Telemedicine Inc. Invited to Attend Democratic National Convention 2Health News:Older Caregivers Prone to Worse Sleep Patterns 2
...iling in their MBBS examinations in Rajasthan need...ical University// is conducting MBBS examinations ...g questioned by many. These examinations are bei...g number of failures in MBBS and to help those stu...
...ng vacated by the National Enquirer after an anthr...fe, more than two years// after cleanup began, acc... editor for American Media Inc., died in October 2...rax in an envelope mailed to the building, which h...
...n health officials have doomsday predictions for t...es are taken// to curb HIV/AIDS infection. Accor... of Malaysia, the country will have a head count o... by 2015. Of a population of 30 million, 73 thous...
...ers of the international Horse Genome Sequencing P... the horse genome// sequence has been completed an...d veterinary researchers around the globe. The fi...ists with a new set of tools for investigating equ...
Other Medicine News:
(Date:8/27/2008)... Memorial Hospital one of 18 centers involved in 1...wire/ -- Results of a 10-year study,published in t...edicine,found that magnesium sulfate administered ...educed the risk of cerebral palsy by 50 percent. T...te (BEAM) trial was,conducted in 18 centers in the...
(Date:8/27/2008)...Phase 3 data, from BLISS-52 trial, expected by mid...6, expected by fall 2009 -, ROCKVILLE, Md., Aug. ..., Inc. (Nasdaq: HGSI ) today announced it has com...the second of two pivotal Phase 3,randomized clini...nts with,active systemic lupus erythematosus (SLE)...
(Date:8/26/2008)...ds most patients can drive safely six weeks follow...PRNewswire-USNewswire/ -- Six weeks following,buni...that they are able to,get back behind the wheel of... issue of The Journal of Bone and Joint Surgery ( ...rake time response in patients who underwent a,fir...
(Date:8/26/2008)...Aug. 26 /- Omeros Corporation today a...se 1/Phase 2 trial investigating,OMS103HP in arthr...ction,surgery. OMS103HP is an investigational drug...solution and is designed to improve postoperative,...n and allow patients an,earlier return to work. Th...
Breaking Medicine Technology:National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births 2National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 2Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 4Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 5Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 6Braking After Bunion Surgery 2Braking After Bunion Surgery 3Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery 2Love and Diabetes 3A dLife Valentines Day Quiz Tests and Teaches Important Relationship Lessons for People With Diabetes 11380 1Love and Diabetes 3A dLife Valentines Day Quiz Tests and Teaches Important Relationship Lessons for People With Diabetes 11380 2Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 1Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 2Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 3Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 4Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 5Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 6Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 7Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 8Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 9Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 10Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 11Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 12Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 13Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 14Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 15Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 16Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 17Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 18Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 19Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 20Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 21Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 22Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 23Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 24Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 25Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 26Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 27Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 28Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 29e Smart 28R 29 Technologies Delivers Its New Super Smart Card 28TM 29 in South Korea 2161 1e Smart 28R 29 Technologies Delivers Its New Super Smart Card 28TM 29 in South Korea 2161 2American Heart Association Themed Issue Journal Report 3A Journal Edition Dedicated to Womens Unique Hypertension Issues 11371 1American Heart Association Themed Issue Journal Report 3A Journal Edition Dedicated to Womens Unique Hypertension Issues 11371 2American Heart Association Themed Issue Journal Report 3A Journal Edition Dedicated to Womens Unique Hypertension Issues 11371 3American Heart Association Themed Issue Journal Report 3A Journal Edition Dedicated to Womens Unique Hypertension Issues 11371 4American Heart Association Themed Issue Journal Report 3A Journal Edition Dedicated to Womens Unique Hypertension Issues 11371 5
...ELPHIA, June 05, 2007 /PRNewswire/ -- , Professor ... are disappointing and,misleading in that they dis...ly relevant to patients and physicians. Most,signi...o evidence,of any increase in cardiovascular death... , CONTACT: Professor Philip Home, (44) 778-525-17...
...d Achieves All Key Endpoints for Both Efficacy and...re-FirstCall/ --,Indevus Pharmaceuticals, Inc. tod...macokinetic trial for NEBIDO (testosterone,undecan...apy under,development for the treatment of male hy...chering Pharma AG, Germany. The data,from the rece...
Other Medicine Technology:Indevus Reports Positive Data From Phase III NEBIDO Trial 2Indevus Reports Positive Data From Phase III NEBIDO Trial 3Indevus Reports Positive Data From Phase III NEBIDO Trial 4Indevus Reports Positive Data From Phase III NEBIDO Trial 5Indevus Reports Positive Data From Phase III NEBIDO Trial 6
...or Digital Thermostat and Digital Display. , Exter...inum ends. , Interiorwhite anodized aluminum with...frigeration (134A). , Temperature range 0C to 10C...-place polyurethane high density cell insulation (...
...ratory system for pH and temperature measurements....d when used with a temperature probe (ATC) or a 3-...oint calibration with Auto-Find automatic buffer r...10.01 and 12.45) and Auto-Read for locking onto st...
... Detectors provide unmatched value and flexibility.... Capable of performing fluorescence, luminescence...t, the DTX Series can operate as standalone instru... Coulters Biomek Laboratory Automation Workstation...
...hput Screening (HTS), Analyst HT smoothes the tran...on modalities and assay performance of Analyst AD,..., time-resolved fluorescence, luminescence, absorb...otic environments, including those from Beckman Co...
Medicine Products: